Antihypertensive treatment in patients with acromegaly is mainly based on the use of angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin II receptor blockers (ARA-II), since they are effective in lowering blood pressure and reducing left ventricular hypertrophy, a frequent complication in this population [95]. This evidence concerns the gene ACE and left ventricular hypertrophy.